[Use of thymogen in the treatment of various forms of acute abdominal disorders in an experiment].
Reznikov. K M KM; Filippova. O V OV; Glukhov. A A AA; Griaznov. D V DV; Banin. I N IN
Key Findings
- Thymogen lowered blood serum alpha‑amylase activity, indicating reduced pancreatic enzyme aggression.
- Tissue levels of malondialdehyde (a marker of lipid peroxidation) were lower in treated rats.
- Antioxidant enzymes (superoxide dismutase and catalase) were better preserved, and leukocytosis was reduced.
Practical Outcomes
- The study shows thymogen has anti‑inflammatory and antioxidant effects in acute abdominal injury in rats, but it provides no human dosing or safety data. For biohackers, it suggests a potential avenue for research, yet it is not ready for real‑world self‑administration or protocol development.
Summary
In a rat study, injecting thymogen into the belly cavity after causing severe pancreas or peritoneum inflammation reduced harmful enzyme activity, oxidative damage, and immune cell over‑reaction, suggesting the peptide can calm acute abdominal inflammation in animals.
Abstract
The authors have carried out experimental studies of thymogen action on the course of acute pancreatitis and acute peritonitis in white albino rat males. The preparation was introduced into the abdominal cavity early after the modeling and every 24 hours for 5 days. The results of the trial demonstrate that the degree of autoenzyme aggression (the data of blood serum alpha-amylolytic activity control) and the content of lipid peroxidation products (assessment of malonic dialdehyde quantity in tissue homogenate) were low in the experimental group as compared to the untreated animals. In the experimental group less pronounced depression of antiradical activity (superoxide dismutase and catalase activity control) was found, leukocytosis and leukocyte intoxication index were diminished. Thus, the efficiency of thymogen in acute inflammatory and destructive abdominal diseases has been proved.
Study Information
pubmed
1998